 SEATTLE, Aug. 24, 2021 PRNewswire -- CTI BioPharma Corp. Nasdaq: CTIC today announced the appointment of Diane Parks to its Board of Directors. Ms. Parks has overseen the launch of numerous hematology and cancer therapies at large pharmaceutical and biotech companies, including Kite Pharma, Amgen, and Genentech. 